SUBSCRIBE
Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2005, Vol. 3 ›› Issue (3): 225-228.doi: 10.3736/jcim20050317

• Original Experimental Research • Previous Articles     Next Articles

Effects of Runing RecipeⅡ on expressions of p53 and ras oncogene proteins and cell cycle of the transplanted Ca761 breast cancer in mice

Qian-jun Chen1,Yi-an Wang1,Hong-lin Situ1,De-min Lu2,Li-ping Ren1,Xi-wen Lai1,Peng-xi Liu1,Yi Lin1   

  1. 1. Department of Breast Diseases, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong Province 510120, China
    2. Department of Breast Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
  • Received:2005-03-28 Online:2005-05-20 Published:2005-05-20
  • Contact: Qian-jun Chen E-mail:cqj55@163.com

RichHTML

1

PDF (PC)

44

Cited

1

Like

Objective

To explore the mechanisms of Runing RecipeⅡ (a recipe composed of traditional Chinese herbs) in inhibiting the growth of breast cancer by observing its effects on the expressions of p53 and ras oncogene proteins and cell cycle of the transplanted Ca761 breast cancer in mice.

Methods

We established the breast cancer model by transplanting Ca761 cells in mice. The mice were randomly divided into 4 groups: normal saline control group, CTX-treated group, Runing RecipeⅡ-treated group, and Runing RecipeⅡand CTX-treated group, with 12 mice in each group. We detected the cell cycle of the cancer cells in the mice’s transplanted tumor with flow cytometry and measured the expressions of p53 and ras oncogene proteins in the transplanted tumor with immunohistochemical methods.

Results

The percentages of tumor cells in S-phase of the Runing RecipeⅡ-treated group, CTX-treated group and Runing RecipeⅡand CTX-treated group were significantly lower than that of the normal saline control group respectively (P<0.05). The percentage of tumor cells in G0-G1 phase of the Runing RecipeⅡ-treated group was lower than that of the CTX-treated group (P<0.05), while the percentage of tumor cells in G2-M phase was higher than that of the CTX-treated group. The immunoreactive scores (IRSs) of p53 in the Runing RecipeⅡ-treated group and Runing RecipeⅡand CTX-treated group were significantly lower than that in the normal saline control group respectively (P<0.05). The effect of CTX on the expression of p53 was not significant. The IRSs of ras oncogene protein in the RecipeⅡ-treated group, CTX-treated group and Runing RecipeⅡand CTX-treated group were lower than that in the normal saline control group respectively (P<0.05).

Conclusion

Runing RecipeⅡ can inhibit the growth of Ca761 breast cancer in mice by controlling the cell cycle of the transplanted tumor. This may be related to its effect on the gene expressions of p53 and ras in the tumor tissue.

Key words: Chinese medicine and pharmacology, Breast cancer, Cell differentiation, Oncoproteins

CLC Number: 

  • R289.91

Tab 1

Percentages of cells in different cell cycles in 4 groups of mice with transplanted Ca761 breast cancer ($\bar{x}$±s, %)"

Group n G0-G1 phase S phase G2-M phase
Normal saline control 8 59.41±4.69 25.43±5.02 14.99±3.42
CTX-treated 8 74.10±4.98* 15.57±3.96* 10.33±3.72*
Runing RecipeⅡ-treated 8 66.25±5.19*△ 18.60±2.21*△ 15.16±4.45△
Runing RecipeⅡand CTX-treated 8 78.19±4.02* 13.03±6.05*△ 8.78±2.76*

Tab 2

Expressions of p53 and ras oncogene proteins in 4 groups of mice with transplanted Ca761 breast cancer ($\bar{x}$±s)"

Group n p53 IRS ras IRS
Normal saline control 10 5.60±2.76 4.70±1.41
CTX-treated 10 4.20±2.53 2.90±0.88*
Runing RecipeⅡ-treated 10 2.40±1.65* 2.70±1.42*
Runing RecipeⅡand CTX-treated 10 2.80±2.30* 2.80±1.03*
[1] EI-Deiry WS, Harper JW , O'Connor PM, et al.WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis[J]. Cancer Res, 1994,54(5):1169-1174
doi: 10.1007/BF01525643 pmid: 8118801
[2] Oda H, Nakatsuru Y, Ishikawa T . Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transfomation in renal cell carcinomas[J]. Cancer Res, 1995,55(3):658-662
[3] 陈前军, 陆德铭, 刘胜 , 等. 中药乳宁Ⅱ号对Ca761小鼠移植性乳腺癌的抑制作用[J]. 实用肿瘤学杂志, 1999,13(4):243-244
[4] 陈前军, 张策, 陆德铭 , 等. "乳宁Ⅱ号"对Ca761小鼠移植性乳腺癌移植瘤细胞分化的影响[J]. 中国中医基础医学杂志, 2001,7(8):34-36
[5] 韩锐 . 抗癌药物研究与实验技术(第1版)[M]. 北京: 北京医科大学中国协和医科大学联合出版社, 1997,( 第1版):439
[6] Friedrichs K, Gluba S, Eidtmann H , et al. Overexpression of p53 and prognosis in breast cancer[J]. Cancer, 1993,72(12):3641-3647
doi: 10.1002/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8 pmid: 8252480
[7] 高慧, 傅松滨, 董辉 , 等. 肿瘤中p16基因的研究进展[J]. 国外医学·遗传学分册, 1999,22(2):61-63
[8] 王志浩 . p53基因结构与功能研究的新进展[J]. 国外医学·遗传学分册, 1999,22(1):25-29
[1] Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64.
[2] Fatemeh Sadat Hasheminas, Seyed Mehdi Hashemi, Azizallah Dehghan, Fariba Sharififar, Mohammad Setayesh, Pegah Sasanpour, Mojtaba Tasbandi, Mahboobeh Raeiszadeh. Effects of a Plantago ovata-based herbal compound in prevention and treatment of oral mucositis in patients with breast cancer receiving chemotherapy: A double-blind, randomized, controlled crossover trial. Journal of Integrative Medicine, 2020, 18(3): 214-221.
[3] Carlos R. Oliveira, Daniel G. Spindola, Daniel M. Garcia, Adolfo Erustes, Alexandre Bechara, Caroline Palmeira-dos-Santos, Soraya S. Smaili, Gustavo J.S. Pereira, André Hinsberger, Ezequiel P. Viriato, Maria Cristina Marcucci, Alexandra C.H.F. Sawaya, Samantha L. Tomaz, Elaine G. Rodrigues, Claudia Bincoletto. Medicinal properties of Angelica archangelica root extract: Cytotoxicity in breast cancer cells and its protective effects against in vivo tumor development. Journal of Integrative Medicine, 2019, 17(2): 132-140.
[4] Syed Nasir Abbas Bukhari, Fahad Hussain, Hnin Ei Thu, Zahid Hussain. Synergistic effects of combined therapy of curcumin and Fructus Ligustri Lucidi for treatment of osteoporosis: cellular and molecular evidence of enhanced bone formation. Journal of Integrative Medicine, 2019, 17(1): 38-45.
[5] Lizhou Liu, Simone Petrich, Blair McLaren, Lyndell Kelly, G. David Baxter. An integrative Tai Chi program for patients with breast cancer undergoing cancer therapy: Study protocol for a randomized controlled feasibility study. Journal of Integrative Medicine, 2018, 16(2): 99-105.
[6] Gloria Gronowicz, Eric R. Secor Jr., John R. Flynn, Liisa T. Kuhn. Human biofield therapy does not affect tumor size but modulates immune responses in a mouse model for breast cancer. Journal of Integrative Medicine, 2016, 14(5): 389-399.
[7] Di Li, Guan-liang Wang, Meng-ya Shan, Jia-han Liu, Lin Wang, De-zeng Zhu. Effects of ursolic acid on c-Cbl-associated protein expression in 3T3-L1 adipocytes with insulin resistance. Journal of Chinese Integrative Medicine, 2012, 10(8): 886-893.
[8] Mei-qun Cao, Zheng-zhi Wu, Wei-kang Wu. Identification of salivary biomarkers in breast cancer patients with thick white or thick yellow tongue fur using isobaric tags for relative and absolute quantitative proteomics. Journal of Chinese Integrative Medicine, 2011, 9(3): 275-280.
[9] Mei-na Ye, Hong-feng Chen, Rui-juan Zhou, Ming-juan Liao. Effects of Astragalus polysaccharide on proliferation and Akt phosphorylation of the basal-like breast cancer cell line. Journal of Chinese Integrative Medicine, 2011, 9(12): 1339-1346.
[10] Ying Deng , Hong-feng Chen. Effects of Astragalus injection and its ingredients on proliferation and Akt phosphorylation of breast cancer cell lines. Journal of Chinese Integrative Medicine, 2009, 7(12): 1174-1180.
[11] Xiao-fei Huang, Ding Yuan, Chang-cheng Zhang, Xiao-peng Zhang. Artesunate induces prostate cancer cell line PC-3 differentiation and cell cycle arrest. Journal of Chinese Integrative Medicine, 2008, 6(6): 591-594.
[12] Mei-na Ye, Hong-feng Chen. Effects of Astragalus injection on proliferation of basal-like breast cancer cell line MDA-MB-468. Journal of Chinese Integrative Medicine, 2008, 6(4): 399-403.
[13] Sheng Liu, Jing Zhao, Jia Liu, Zhen-ping Sun, Yong-qiang Hua, De-ming Lu, Han-jun Tang. Effects of Ru'ai Shuhou Recipe on 5-year recurrence rate after mastectomy in breast cancer. Journal of Chinese Integrative Medicine, 2008, 6(10): 1000-1004.
[14] YUAN Ding, ZUO Rui, cheng ZHANG Chang. Effects of total saponins of Panax japonicus on human leukemic HL-60 cells. Journal of Chinese Integrative Medicine, 2007, 5(5): 570-572.
[15] Zhi-qing Cheng, Hong-fei Liu, Juan Zhang, Hang-ping Yao. Th cell differentiation in chronic stage of viral myocarditis in mice and interference of Qingxin-Ⅱ Recipe. Journal of Chinese Integrative Medicine, 2007, 5(3): 318-321.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[7] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022
Journal of Integrative Medicine, ISSN: 2095-4964 CN 31-2083/R
Copyright © Journal of Integrative Medicine
Powered by Beijing Magtech Co. Ltd
沪公网安备31010602003416号      沪ICP备18017633号-3